VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Wednesday reported a loss of $50.3 million in its third quarter.

The Victoria, British Columbia-based company said it had a loss of 39 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.

The biotechnology company posted revenue of $14.7 million in the period, which matched Street forecasts.

Aurinia shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News